Robert M. Lorence

4.5k citations
51 papers · 3.8k · 2 hit papers · h-index 27

Impact in

Papers in

Robert M. Lorence

49 papers receiving 3.6k citations

Robert M. Lorence's Hit Papers

Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial 2012 · 839 citations
8390+4+9Years since publication250500750

Peers

Robert M. Lorence
Comparison fields: 5 of 86
  • Genetics 1.4k
  • Pulmonary and Respiratory Medicine 1.1k
  • Inorganic Chemistry 298
  • Behavioral Neuroscience 52
  • Immunology 239
Replace Kathy Hsiao with:
Kathy Hsiao United States
Eric N. Hampton United States
Todd W. Ridky United States
Wen Chen China
Yun Gao China
Yan‐Hwa Wu Lee Taiwan
Gordon A. Vehar United States
Mark Leo Michaels United States
Yiwei Huang China
Merry Rubin Sherman United States
Robert M. Lorence relative to Kathy Hsiao United States Kathy Hsiao's profile →
Citations per field
00.5×5×10×13.9×
Kathy Hsiao · 1×
Citations per year

Countries citing papers authored by Robert M. Lorence

Since Specialization
Citations

This map shows the geographic impact of Robert M. Lorence's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert M. Lorence with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert M. Lorence more than expected).

Fields of papers citing papers by Robert M. Lorence

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert M. Lorence. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert M. Lorence. The network helps show where Robert M. Lorence may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert M. Lorence, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert M. Lorence Line = papers co-authored together Robert M. Lorence links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial
Hit paper breakdown →
2012839
2
Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): a phase 2 trial
Hit paper breakdown →
2012357
3 2002338
4 1992208
5 2001144
6
Complete regression of human fibrosarcoma xenografts after local Newcastle disease virus therapy.
1994136
7 1988130
8 1991112
9 1994111
10 2006107
11 2007103
12 198699
13 200799
14 199295
15 198091
16 199182
17 201877
18 201368
19 198463
20 198458

About Robert M. Lorence

Robert M. Lorence is a scholar working on Genetics, Pulmonary and Respiratory Medicine, Inorganic Chemistry, Materials Chemistry and Immunology, having authored 51 papers that have together received 3.8k indexed citations. Recurring topics across this work include Virus-based gene therapy research (17 papers), Lung Cancer Treatments and Mutations (13 papers), Bacterial Genetics and Biotechnology (8 papers), Enzyme Structure and Function (8 papers), Virology and Viral Diseases (5 papers), Metal-Catalyzed Oxygenation Mechanisms (5 papers), Mitochondrial Function and Pathology (3 papers) and Growth Hormone and Insulin-like Growth Factors (3 papers). The work is most often cited by research in Genetics (1.4k citations), Pulmonary and Respiratory Medicine (1.1k citations), Inorganic Chemistry (298 citations), Behavioral Neuroscience (52 citations) and Immunology (239 citations). Robert M. Lorence has collaborated with scholars based in United States, Taiwan and Germany. Frequent co-authors include Robert B. Gennis, Robert J. Walter, Kirk W. Reichard, Mark E. Peeples, Keith W. Kelley, James Chih‐Hsin Yang, William S. Groene, M. Scot Roberts, Xiuyu Julie Cong and Michael K. Bamat. Their work appears in journals such as Journal of Biological Chemistry, European Journal of Cancer, JNCI Journal of the National Cancer Institute, Journal of Thoracic Oncology and The Lancet Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact